Montag A & Associates Inc. Invests $35,000 in Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Montag A & Associates Inc. bought a new stake in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAPFree Report) during the 4th quarter, Holdings Channel reports. The firm bought 1,800 shares of the company’s stock, valued at approximately $35,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Van ECK Associates Corp grew its stake in shares of Crescent Capital BDC by 2.3% during the 4th quarter. Van ECK Associates Corp now owns 45,562 shares of the company’s stock valued at $876,000 after acquiring an additional 1,006 shares during the period. Hennion & Walsh Asset Management Inc. boosted its position in shares of Crescent Capital BDC by 11.9% in the fourth quarter. Hennion & Walsh Asset Management Inc. now owns 105,343 shares of the company’s stock worth $2,025,000 after purchasing an additional 11,161 shares during the period. Redhawk Wealth Advisors Inc. purchased a new stake in shares of Crescent Capital BDC in the fourth quarter worth $659,000. Confluence Investment Management LLC increased its stake in Crescent Capital BDC by 0.9% in the 4th quarter. Confluence Investment Management LLC now owns 73,839 shares of the company’s stock worth $1,419,000 after buying an additional 633 shares in the last quarter. Finally, Franklin Resources Inc. grew its position in shares of Crescent Capital BDC by 35.2% during the third quarter. Franklin Resources Inc. now owns 256,279 shares of the company’s stock worth $4,726,000 after purchasing an additional 66,713 shares in the last quarter. Hedge funds and other institutional investors own 49.46% of the company’s stock.

Crescent Capital BDC Price Performance

NASDAQ:CCAP opened at $20.00 on Wednesday. The firm has a market capitalization of $741.20 million, a price-to-earnings ratio of 7.84 and a beta of 0.81. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.26 and a quick ratio of 1.26. The business has a 50 day simple moving average of $19.47 and a 200-day simple moving average of $18.85. Crescent Capital BDC, Inc. has a 1 year low of $16.18 and a 1 year high of $20.19.

Crescent Capital BDC Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Investors of record on Tuesday, December 31st were given a $0.42 dividend. The ex-dividend date of this dividend was Tuesday, December 31st. This is an increase from Crescent Capital BDC’s previous quarterly dividend of $0.07. This represents a $1.68 dividend on an annualized basis and a yield of 8.40%. Crescent Capital BDC’s dividend payout ratio (DPR) is currently 65.88%.

Analysts Set New Price Targets

Several analysts have commented on the stock. Wells Fargo & Company boosted their price target on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 29th. Keefe, Bruyette & Woods boosted their target price on Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a research report on Monday, November 25th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $19.33.

View Our Latest Stock Report on CCAP

Crescent Capital BDC Company Profile

(Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

See Also

Want to see what other hedge funds are holding CCAP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crescent Capital BDC, Inc. (NASDAQ:CCAPFree Report).

Institutional Ownership by Quarter for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.